Terrasil Ipl Relief Maximum Strength
Thuja Occidentalis
Aidance Skincare & Topical Solutions, Llc
Human Otc Drug
NDC 24909-147Terrasil Ipl Relief Maximum Strength also known as Thuja Occidentalis is a human otc drug labeled by 'Aidance Skincare & Topical Solutions, Llc'. National Drug Code (NDC) number for Terrasil Ipl Relief Maximum Strength is 24909-147. This drug is available in dosage form of Ointment. The names of the active, medicinal ingredients in Terrasil Ipl Relief Maximum Strength drug includes Thuja Occidentalis Leafy Twig - 3 [hp_X]/g . The currest status of Terrasil Ipl Relief Maximum Strength drug is Active.
Drug Information:
| Drug NDC: | 24909-147 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Terrasil Ipl Relief Maximum Strength |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Proprietary Name Base: | Terrasil Ipl Relief |
| The base of the Brand/Proprietary name excluding its suffix. |
| Proprietary Name Suffix: | Maximum Strength |
| A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Thuja Occidentalis |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Aidance Skincare & Topical Solutions, Llc |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Ointment |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | THUJA OCCIDENTALIS LEAFY TWIG - 3 [hp_X]/g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 14 Mar, 2014 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 15 Jun, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Aidance Skincare & Topical Solutions, LLC
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | 1NT28V9397
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 24909-147-14 | 14 g in 1 JAR (24909-147-14) | 14 Mar, 2014 | N/A | No |
| 24909-147-15 | 14 g in 1 TUBE (24909-147-15) | 29 Dec, 2018 | N/A | No |
| 24909-147-44 | 44 g in 1 JAR (24909-147-44) | 14 Mar, 2014 | N/A | No |
| 24909-147-50 | 50 g in 1 TUBE (24909-147-50) | 29 Dec, 2018 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose papule and naevi symptom relief
Product Elements:
Terrasil ipl relief maximum strength thuja occidentalis thuja occidentalis leafy twig thuja occidentalis leafy twig bentonite cottonseed oil jojoba oil juniperus virginiana oil magnesium oxide peppermint oil silver oxide stearic acid white wax zinc oxide
Indications and Usage:
Uses relief from symptoms of itch, papules (bumps) and lesions often associated with molluscum per diagnosis and care by physician.
Warnings:
Warnings for external use only. virally based infections are contagious. this product will not stop the spread of molluscum or other viruses. do not use - in the eyes - over large areas of the body - if you are allergic to any ingredient in this product. ask a doctor before use if pregnant or nursing. stop use and ask a doctor if condition worsens or symptoms persist for more than 7 days.
Dosage and Administration:
Directions wash and dry affected skin. apply a thin layer of terrasil 2-3 times daily. store at room temperature.
Package Label Principal Display Panel:
Principal display panel - 14g tube all natural terrasil® ipl relief max terrasil